RE: IMVHO deal chances are remote at best6 Jun 2022 19:23
Hi nom
I hope you are correct, so why the delayed delay?
“TheoremRx reports that it continues to make good progress with its financing, however current global macro-economic events have impacted the timelines. Upon successful completion of the financing by TheoremRx, the first payments to ValiRx under the sub-license are anticipated on or before end-June 2022.”
Surely when TheoremRX first started doing a few sums on the back of a cigarette packet up the pub, the figures were more favourable?
Now we have increased costs in borrowing and increased costs in materials, labour, are you saying this will not have affected the chances of successful borrowing?
OB